StockData
Takeda Pharmaceutical Co Ltd logo

Takeda Pharmaceutical Co Ltd (TAK) stock

TAKNYSEPharmaceutical PreparationsAlso trades as TKPHF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Last filing: 20-F on Jun 17, 2026Score 5/30
$21.27−0.37 (-1.71%)

Close on Nov 18, 2026Market cap $73.30BP/E –Yield –

Takeda Pharmaceutical pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Takeda Pharmaceutical's pe ratio was 75.6× on May 29, 2026, against 47.5× a year earlier. Over the last 5 years it ranged from 12.7× to 87.6×, with a median of 28.2×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026May 29, 202675.6×+2.9
2025Dec 31, 202572.7×+27.0
2024Dec 31, 202445.7×+25.8
2023Dec 29, 202319.9×−8.3
2022Dec 30, 202228.2×+15.1
2021Dec 31, 202113.1×−119.8
2020Dec 31, 2020133.0×+102.3
2019Dec 31, 201930.7×+15.1
2018Dec 31, 201815.5×−28.3
2017Dec 29, 201743.8×–

More Takeda Pharmaceutical figures

See a number that looks wrong?